Oxford Pharmascience Group (OXP)


Latest News

OXP receives MHRA advice on OXPzero

Oxford Pharmascience has confirmed that the Company has received written advice from the MHRA (UK regulatory au...

MHRA Advice on OXPzeroT Ibuprofen OTC Opportunity

RNS Number: 3946S Oxford Pharmascience Group PLC 02 October 2017 2 October 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") MHRA Advice on OXPzero TM Ibuprofen OTC Opportunity Oxford Pharmascience, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, t...

Interim Results

RNS Number: 6364R Oxford Pharmascience Group PLC 25 September 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Interim results for the six months to 30 June 2016 Oxford Pharmascience Group Plc (AIM: OXP) is pleased to announce its unaudited interim results for the six months to 30 June 2017. Recent clinical work confir...

All resolutions passed at AGM of Oxford Pharmascience

Oxford Pharmascience Group has confirmed that all resolutions were passed by shareholders at today's Annual General M...

All News

02-10-17OXP receives MHRA advice on OXPzeroStockMarketWire
02-10-17MHRA Advice on OXPzeroT Ibuprofen OTC OpportunityRNS
25-09-17Interim ResultsRNS
19-06-17All resolutions passed at AGM of Oxford PharmascienceStockMarketWire
19-06-17Result of AGMRNS
08-06-17Further Update re: OXPzero Ibuprofen ProgrammesRNS
09-05-17Update regarding OXPzeroTM Ibuprofen ProgrammesRNS
31-03-17Miners drag on FTSE as commodity prices fall StockMarketWire
31-03-17Second Price Monitoring ExtnRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Price Monitoring ExtensionRNS
31-03-17Oxford Pharmascience disappointed with FDA feedbackStockMarketWire
31-03-17FDA Feedback on OXPzeroT Ibuprofen Rx ProgrammeRNS
10-03-17Oxford Pharmascience narrows FY pretax lossStockMarketWire
10-03-17Final ResultsRNS
07-03-17Notice of ResultsRNS
23-02-17Company UpdateRNS
25-01-17Oxford Pharmascience - Company updateBRR Media
17-01-17Oxford Pharmascience issues company updateStockMarketWire
17-01-17Company UpdateRNS
09-11-16R&D UpdateRNS
19-10-16Here's what Neil Woodford is buying and sellingInteractive Investor
13-09-16Oxford Pharmascience - Interim results 2016BRR Media
07-09-16Interim results for the 6 months to 30 June 2016RNS
21-07-16Oxford Pharmascience downgraded by BeaufortStockMarketWire
21-07-16Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLCStockMarketWire
20-07-16FTSE rises on pharmas, financials as miners ebbStockMarketWire
20-07-16Commercial Update & Directorate ChangeRNS
22-06-16Result of AGMRNS
20-05-16Shares Magazine Investor Evening PresentationRNS
22-04-16OXP to exhibit at the Master Investor Show 2016RNS
22-04-16Oxford Pharmascience Group plc - Company updateBRR Media
19-04-16Positive Regulatory Advice from MHRARNS
11-03-16Grant of Share OptionsRNS
04-03-16Oxford Pharmascience widens FY pretax lossStockMarketWire
04-03-16Final ResultsRNS
01-03-16Oxford Pharmascience schedules FY results StockMarketWire
01-03-16Notice of ResultsRNS
25-02-16Appointment of DirectorRNS
29-01-16Change of Registered OfficeRNS

RSS feeds

  • Editorial news feed for LSE:OXP Editorial
  • Regulatory news feed for LSE:OXP Regulatory